Seven years after the biotechnology firm launched, Akero Therapeutics is slated to be acquired by the Danish pharmaceutical giant Novo Nordisk in a deal worth up to $5.2 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback